Primary Prevention of Stroke in Children With SCD in Sub-Saharan Africa II "SPRING"


Phase 3 Results N/A

Summary of Purpose

The overall goal of this proposal is to conduct a partial double-blind randomized Phase III clinical trial for primary stroke prevention in children with sickle cell anemia (SCA) in sub-Saharan Africa.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 28 March 2018.

1 Jul 2016 2 Sep 2015 1 Dec 2021 1 Dec 2021 1 Mar 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Investigator, Outcomes Assessor)
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment


  • Michael R. DeBaun, MD, MPH

  • Muktar Aliyu, MBBS, MPH, DrPH